ArticleFrontiers in oncology2026

Moderate-to-good acceptability of smartwatch monitoring in head and neck cancer survivors: findings from the MOVE-1 feasibility study.

Karl Vietinghoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.